Overview

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Status:
RECRUITING
Trial end date:
2032-01-13
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops tiny open ulcers).
Phase:
PHASE3
Details
Lead Sponsor:
Janssen Research & Development, LLC